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1. Introduction  
Natural products are chemical substances produced by living organisms of the Biota 
superdomain, namely plants, animals, fungi and bacteria (G. & C. Merriam Co., 1913). Up to 
80% of all drugs discovered prior to 1981 and 50% of all approved drugs between the years 
1994 and 2007 are of natural product origin (Harvey, 2008). The contribution of natural 
products derived from plants, particularly to the well-being of mankind, extends very far back 
in history. Some of the most famous findings supportive of this fact come from the Middle 
East region and include documented medical papyri of ancient Egyptians dating back to ca. 
1,850 B.C., as well as recent studies revealing their use of medicinal herbs dispensed in grape 
wine ca. 3,150 B.C. (McGovern et al., 2009). Incidentally, the oldest evidence for the use of 
herbal medicine to be so far discovered dates back to the prehistoric Neanderthal man who 
lived also in the Middle East region around 60,000 years ago (Solecki, 1971).  
Several world heritages of medicinal plants have also inspired and greatly contributed to the 
development of modern medicine (Azaizeh et al., 2008).  Indeed some of the early drugs 
were derived from plants. Morphine, for instance, was the first pharmacologically active 
pure compound to be extracted from a plant over 200 years ago (Jesse et al., 2009). Clinical, 
pharmacological, and chemical studies have since then led to the identification of a lengthy 
list of drugs derived from plants covering a wide range of diseases from diabetes, malaria, 
microbial infections, osteoporosis to inflammation and cancer.  
The story of the discovery of plants exhibiting anticancer properties in particular, began 
almost fifty years ago. With the increase in cancer incidences, there has been an increase of 
interest in screening for anti-tumor agents from diverse sources including plants. For that 
purpose, in 1960 the National Cancer Institute (NCI) launched a large-scale screening of 
35,000 sample plants. The program resulted among others, in the discovery in 1967 of the 
best-selling anticancer drug today; Taxol (Cragg, 1998). This breakthrough boosted cancer 
researchers all over the world and especially those in regions with high diversity to explore 
the indigenous plants’ active ingredients efficacy against cancer. Considering that more than 
60% of anticancer drugs available for clinical use today are derived from natural products 
including plants (Balunas et al., 2005; Newman and Cragg, 2007), one cannot deny that there 
has been a successful contribution of plants to the fight against cancer (reviewed in Gali-
Muhtasib and Bakkar, 2002; Darwiche et al.,  2007).  
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Lebanon falls within the Levantine Uplands center of diversity. Compared to other 
Mediterranean countries, it stands second after Turkey in its floristic diversity with 2600 
plant species distributed around its humble 10452 km2 (Nehmeh, 1977).  About 311 plants 
corresponding to 12% of the total plant species are endemic to Lebanon and have been used 
in part by Lebanese folk medicine practitioners and Lebanese people for preventive and 
therapeutic purposes (Nehmeh, 1977).  As members of the Nature Conservation Center for 
Sustainable Futures (IBSAR), we have been leading research over the past 10 years for the 
understanding and evaluation of Lebanese indigenous plant properties against various 
conditions, especially cancer. The following chapter aims at retracing our adventure with 
“Salograviolide A” (Sal A), and bringing to light this peculiar molecule that exhibits both 
anti-inflammatory and anticancer effects.  
2. Sesquiterpene lactones in traditional and conventional medicine  
Sesquiterpene lactones (SLs) are generally colourless bitter phytochemicals of lipophylic 
nature. Thousands of molecules are classified in the SLs subfamily of the terpenoids group 
of plant secondary metabolites. They are predominantly isolated from leaves or flowering 
heads of plants of the sunflower family Asteraceae and to a limited extent from 
Umbelliferae and Magnoliaciae (Heywood et al., 1977). The percentage of SLs per plant dry 
weight often exceeds 1% (Heywood et al., 1977).  
The benefits of many plants enriched with SLs have been described in depth in 
Mediterranean folk literature with emphasis on their laxative values as well as their 
potential for the treatment of sores, wounds, sprains, fever, pain, headaches, malaria, 
anaemia, microbial infections, arthritis, cough, bronchitis, diabetes, hypertension and 
inflammation (Awadallah, 1984; Moukarzel, 1997). 
Similarly, scientific literature supports most of the SLs activities attributed to their plants of 
origin in traditional medicine such as the hypoglycemic (Genta et al., 2010), antibacterial 
(Bach et al., 2011), antifungal (Vajs et al., 1999), antiplasmodial (Medjroubi et al., 2005), 
antinociceptive, antipyretic (Akkol et al., 2009) and anti-inflammatory (Al-Saghir et al., 2009) 
effects.  
There are to date around 1500 publications that have reported the anticancer and anti-
inflammatory properties of SLs. Three major SLs and/or many of their synthetic derivatives 
have reached phase I-II cancer clinical trials, namely thapsigargin from Thapsia garganica 
(Apiaceae), artemisinin and artesunate from Artemisia annua, and parthenolide from 
Tanacetum parthenium (Fig. 1) (reviewed in Ghantous et al., 2010). These SLs have properties 
that enable them to target tumor cells and cancer stem cells while sparing normal cells. They 
also affect different cancers or inflammation conditions. For example, thapsigargin 
demonstrated promising results against advanced solid tumors (breast, kidney and 
intestine) while parthenolide had an effect on blood and lymph nodes tumors (reviewed in 
Ghantous et al., 2010). Artemisinin showed efficacy against lupus nephritis, metastatic 
breast and colorectal cancer while clinical evidence indicated that artesunate is effective 
against nonsmall cell lung cancer, metastatic uveal melanoma and laryngeal squamous cell 
carcinoma (Berger et al., 2005; Christensen et al., 2009; Efferth, 2006; Guzman et al., 2007, as 
cited in Ghantous et al., 2010). The chemical basis for the observed biological activities of 
SLs has been reviewed by our group recently (Ghantous et al., 2010). 
Centaurea is one of the largest genera of the Asteracae family with almost 250 species (Font et 
al., 2008). Plants belonging to the Centaurea genus are native to Eurasia. They were 
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introduced to North America around the late 1800’s and can now be found all around the 
world. Centaurea extracts have also been used in traditional medicine for their effects as 
stimulants, diuretics, analgesics, anti-rheumatics, anti-microbial, anti-diabetics and anti-
inflammatory (refer to www.ibsar.org). Anecdotally; the genus’ name is a dedication to the 
centaur Chiron who, according to Greek mythology, had discovered the curative properties 
of these medicinal plants (Nehmeh, 1977). Scientists eventually investigated the medicinal 
properties traditionally attributed to the Centaurea genus and isolated a multitude of SLs in 
addition to other various types of compounds  such as alkaloids, lignans, acetylenes and 
flavonoids. When entering on PubMed the search terms “Centaurea and sesquiterpene 
lactones”, and adding to them the hits from the search “Centaurea and cancer”, 46 results 
get displayed. We investigated the number, nature and biological activity of SLs in the 
different species and summarized some of them in Table 1.  
 
          Artemisia annua                       Tanacetum parthenium                   Thapsia garganica 
 
               Artemisinin                                  Parthenolide                                 Thapsigargin 
 
Fig. 1. Illustration of the sesquiterpene lactones that have reached clinical trials, namely 
thapsigargin extracted from Thapsia garganica, artemisinin from Artemisia annua L., and 
parthenolide from Tanacetum parthenium. The plants pictures are courtesy of Mr. Luigi 
Rignanese, Mr. Peter Griffee and Mr. Paul Drobot, respectively. 
Table 1 indicates that there are at least 89 SLs in 10 Centaurea species. As expected, the 
amount of the SLs as well as their nature is species-specific. Also, the activities of the 
represented SLs cover most of those attributed to the plants in traditional medicine. Aside 
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from Sal A, several articles have reported anticancer properties of SLs extracted from 
Centaurea species (Bruno et al., 2005; Chicca et al., 2011; Csupor-Löffler et al., 2009; El-Najjar 
et al., 2007; Ghantous et al., 2007; González et al., 1980; Koukoulista et al., 2002; Saroglou et 
al., 2005). 
 
Plant Number of 
SLs 
Example of SLs Activity Reference 
 
C. bella  
 
26 Repin Anti-tumor 1, 2  
C. musimomum 
 
11 Cynaropicrin Antiplasmodial 
Cytotoxic 
3, 4 
C. napifolia 
 
4 Cnicin 
 
Antibacterial 
Cytotoxic  
1, 5 
C. nicolai  
 
5 Kandavanolide Antifungal  6 
C. pullata 
 
10 Melitensin Antibacterial 
Antifungal 
7 
C. scoparia  
 
 
 
9 Chlorohyssopifolin Anti-tumor 
Antiviral 
Antimicrobial  
8, 9, 10 
C. solstitialis 
 
 
 
7 Solstitialin A Hypoglycemic 
Antiviral 
Antimicrobial 
11, 12, 13, 14  
C. spinosa 
 
 
10 Malacitanolide Antibacterial  
Cytotoxic 
15 
C. sulphurea  
 
3 Sulphurein - 16 
C. tweediei  
 
 
4 Onopordopicrin 
 
Antibacterial 
Antifungal  
Cytotoxic  
5, 17, 18  
1: Bruno et al., 2005 – 2: Nowak et al., 1993– 3: Cho et al., 2004 – 4: Medjroubi et al., 2005– 5: Bach et al., 
2011 – 6: Vajs et al., 1999 – 7: Djeddi et al., 2007, 2008 – 8: González et al., 1980 – 9: Ozçelik et al., 2009 – 
10: Youssef et al., 1994, 1998 – 11: Akkol et al., 2011 – 12: Cheng et al., 1992 - 13: Gürbüz et al., 2007 – 14: 
Ozçelik et al., 2009 – 15: Saroglou et al., 2005 – 16: Lakhal et al., 2010 – 17: Fortuna et al., 2001 – 18: 
Lonergan et al., 1992.  
Table 1. Sesquiterpene lactones of different Centaurea species and their biological activities. 
3. Salograviolide A: Isolation and chemical characterization 
In 1992, Daniewski et al. isolated an unusually hydroxylated SL from the aerial parts of the 
plant Centaurea salonitana Vis. of Bulgarian origin collected in the Greek region Gravia (Fig. 
2a). The compound was baptised “Salograviolide A” with the prefix “salo” referring to the 
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species salonitana from which it was isolated, “gravi” in allusion for the region Gravia and 
finally the suffix “olide” indicating the presence of a lactone group. 
The first procedure used for the isolation and characterization of Sal A (Fig. 2b) included 
drying the plant and grinding it to a powder. This was followed by dividing the dry 
material (600 g) into three parts that were each soaked in 1 l of methanol (MeOH) for 24 h. 
The extracts were afterwards combined, evaporated (7.5 g) and dissolved in a mixture of 
equal amounts of water and chloroform (H2O-CHCl3 (1:1)). The aqueous layer was extracted 
three times with chloroform alone and the final step consisted of evaporating the extract and 
subjecting it to two separate chromatography techniques for optimal purification, thin layer 
chromatography (TLC) and column chromatography (CC). Infra Red (IR), high resolution 
Mass Spectrum (MS) and 1H and 13C Nuclear Magnetic Resonance (NMR) spectroscopy 
techniques enabled the identification of the structure of Sal A that was later confirmed by 
Rychlewska et al. (1992) using crystal X-ray diffraction techniques. 
Sal A is a 3ǃ-acetoxy-8ǂ, 9ǃ-dihydroxy-lǂH, 5ǂH, 6ǃH, 7ǂH-guaian-4(15), 10(14), 11(13)-
trien-6, 12-olide with the molecular formula C17H20O6. It is classified according to its 
carbocyclic skeleton in the guaianolides group, one of the major groups of SLs. Comprised 
of 15 carbons (15-C) as indicated by the prefix “sesqui”, Sal A has 3 isoprene (5-C) units and 
a lactone group (cyclic ester) (Fig. 2c). The presence of this ǂ-methylene-Ǆ-lactone is thought 
to be responsible for the biological activity of Sal A because of its ability to react with 
nucleophiles by a Michael-type addition (Ghantous et al., 2010). 
Sal A was subsequently isolated from other Centaurea species, namely from C. nicolai Bald 
(Vajs et al., 1999) and from C. ainetensis Bois by bioguided fractionation following an 
extraction scheme adopted from Harborne (1998) (Saliba et al., 2009). 
4. IBSAR efforts for bringing Sal A to the forefront 
Ibsar, AUB’s nature conservation center for sustainable futures, is an interdisciplinary and 
interfaculty center founded in the year 2002 by AUB faculty.  Ibsar’s mission is "to promote 
the conservation and sustainable utilization of biodiversity in arid and Mediterranean 
regions by providing an open academic platform for innovative research and development", 
and its vision is "for societies to become guardians and primary beneficiaries of biodiversity 
in the region" (www.ibsar.org).  
Very early in its establishment, Ibsar recognized that the Lebanese floristic richness also 
represents an untapped resource for the potential discovery of new therapeutic agents 
and/or useful dietary supplements. As a result, one of the key program areas in Ibsar has 
been to integrate traditional knowledge and biotechnology. The objective of this program is 
to discover useful therapeutic agents that may be hidden in wild Lebanese plants and to 
develop products attractive to biotechnology industries. Towards this end, plants from the 
region are collected, extracted and tested for their potential effects on major diseases such as 
cancer, inflammation, microbial infections, skin diseases and diabetes as well as their value 
in nutrition and use for general health purposes. 
C. ainetensis (Arabic name; Qanturyun Aynata or Shawk al-dardar) whose specimen is 
deposited at the herbarium of the American University of Beirut (Lebanon), is an endemic 
plant to Lebanon. It flowers from May to June, has purplish tube of anthers and can only be 
found growing wild in stony, sterile or bushy places in particular areas in Lebanon, mainly 
Dayr-ul-Ahmar to Aynata region at elevations of 1200–1800 m above sea level respectively, 
and in Anti-Lebanon Mountain range above Ayn-Burday at 1250–1300 m (Dinsmore, 1932 as 
cited in Talhouk et al., 2008).  
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(a) Left: Photo of the plant Centaurea salonitana of Portuguese origin. Right: 
The aerial part of the plant 
 
 
(b) Procedure for extraction of Sal A, C17H20O6 
 
 
(c) Chemical structure of Sal A. 
Fig. 2. Illustration of Centaurea salonitana, the procedure of Sal A extraction and its chemical 
structure. 
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The plant was collected during its flowering season and water extract was obtained from it 
by decoction. Briefly, the plant was air dried and soaked either entirely or only its ground 
flower head in hot boiling water for 20-30 min with a ratio of plant material weight to water 
volume of 1/8 (1 g of plant for every 8 ml of water). The solution was filtered either through 
3 mm Whatman filter or through Sterile Gauze sponges 30x30 cm which yielded a residue 
and a filtrate named the “crude water extract”. The resulting aqueous layer was sterilized 
using 0.2 µm non-pyrogenic sterile-R filter before storing it at -20°C until use.  
C. ainetensis water extract is claimed in Lebanese folk literature to have anti-inflammatory 
effects. However, no research paper prior to 2004 investigating this plant’s biological 
activity had ever been published. A screening of 29 plants reported by traditional medicine 
practitioners to have anti-inflammatory effects led to the validation of this activity for C. 
ainetensis water extract (Talhouk et al., 2008). Moreover, a screening of 109 wild Lebanese 
plant extracts, including 41 crude water, 34 methanol and 34 chloroform extracts, has 
resulted in the identification of selective and anti-proliferative bioactivity against several 
cancer cell lines in four wild Lebanese plant species namely, Achillea damascene also known 
as Achillea falcata, Centaurea ainetensis, Onopordum cynarocephalum and Ranunculus 
myosuroudes (Table 2). Although, in vitro, the three other plant extracts showed higher 
activities than C. ainetensis, the latter extract demonstrated the highest tumor growth 
inhibition ranging from 73 to 79% when tested in vivo in a mouse model of colorectal cancer 
(El-Najjar et al, 2007).  
It was also shown later, that C. ainestensis water extract was mildly toxic but largely 
inhibited metastasis of leukemic cells (El-Sabban, unpublished findings).  
Finally the extract was tested against the Infectious Bursal Disease (Gumboro) Virus (IBDV) 
in broilers and showed a mild reduction of IBDV viral antigens in the Bursa of Fabricius as 
well as a mild reduction in bursal lesions (Barbour, unpublished findings). 
In an attempt to unravel the underlying causes for C. ainetensis water extract activity, we 
isolated the bioactive compound Sal A. The plant was subjected to bio-assay guided 
fractionation which consisted of testing the anti-tumor, anti-inflammatory and cytotoxicity 
effects of each fraction of the plant extract. Fractions of the crude water extract were 
inactive; however, Sal A was obtained from a fractionation of the methanol crude extract.  
Sal A manifested the same biological activities as the crude water extract with greater 
efficacy at lower concentrations.  A parallel study was conducted to assess the effect of both 
the water crude extract and methanol crude extract of C. ainetensis along with 26 other 
indigenous Lebanese plants against nine microbial species. The results showed that the 
crude water extract was inactive against all microbial species whereas the methanol extract 
was effective against 88.8% of the tested microorganisms (Barbour et al., 2004). 
Fig. 3 summarizes the acid-base extraction procedure used to fractionate the methanol crude 
extract and isolate Sal A. First the methanol crude extract was obtained by soaking the dried 
plant flowers in methanol with w/v of 1/10 for 16 h. 
The mixture was then incubated on a shaker for 2 h at 20°C. The extract was filtered and 
yielded a residue and a filtrate named the “methanol crude extract”. For further 
fractionation, the residue issued from the methanol extraction was soaked in EtOAc mixture 
in a ratio of 10/1 w/v. It was then separated by filtration into a residue and a filtrate 
consisting of fat and waxes and numbered I.1. To the crude methanol extract, concentrated 
H2SO4 solution was then added drop-wise till the pH reached 2. Following, a mixture of 
CHCl3-H2O (2:1 ratio) was added. The CHCl3 phase enriched with terpenoids and phenols 
was collected and labeled as I.2. The aqueous layer, on the other hand, was basified to pH 10 
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Plant Name in 
Arabic 
Concentration 
(%)* 
Growth 
Inhibition (%) 
Cell line 
 
Achillea damascene 
 
 
Akhilia zat al-
alf waraqah 
 
 
0.5 
 
3 
3 
3 
 
 
65 
 
85 
80 
70 
 
Breast: 
Scp2 
Colon/intestine: 
HCT-116 
HT-29 
Mode K 
 
 
Centaurea 
ainetensis 
 
Quanturyun 
Aynata/ 
Shawk  
al-dardar 
 
 
3 
 
3 
3 
5 
 
3 
3 
3 
3 
3 
 
 
60 
 
60 
80 
50 
 
40 
87 
65 
67 
40 
 
Breast: 
Scp2 
Colon/intestine: 
HCT-116 
HT-29  
Mode K 
Skin: 
PMK 
SP1 
308 
PAM212 
17  
 
 
Onopordum  
cynarocephalum 
 
Aqsun 
harshafi  
al ra’s 
 
0.1 
 
0.5 
0.5 
1.5 
 
 
50 
 
70 
50 
50 
 
Breast: 
Scp2 
Colon/intestine: 
HCT-116 
HT-29 
Mode K  
 
 
Ranunculus 
myosuroudes 
 
Hawdhan 
  
 
2 
2 
2 
2 
2 
 
 
36 
98 
64 
61 
20 
 
Skin: 
PMK 
SP1  
308 
PAM212  
17 
 
Table 2. Representation of the four Lebanese plant extracts with anticancer potentials. The 
following results were obtained for the water extracts of A. damascene, C. ainetensis and O. 
cynarocephalum and the methanol extract of R. myosuroudes. Cell proliferation and 
cytotoxicity were determined using the CellTiter 96 Non-Radioactive Cell Proliferation 
Assay and the CytoTox 96 Non-Radioactive Cytotoxicity Assay (both kits from Promega, 
Madison, WI) according to the manufacturer’s suggestions.  
* % = Volume extract/ Volume media 
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by adding concentrated NH4OH drop-wise and then resuspended in a CHCl3-MeOH 
mixture (3:1 ratio) to be later separated into two organic and aqueous layers labeled I.3 
containing alkaloids and I.4, respectively. I.1, I.2, I.3 and I.4 were evaporated to dryness 
under reduced pressure and weighed. A known amount of each subfraction was dissolved 
in a known volume of suitable solvent for further chromatographic and or/bioassays 
analysis. 
Fraction “I.2” was the only of three other fractions to exhibit activity against cancer cells and 
in models of inflammation. Therefore TLC, thick layer chromatography and CC were used 
to further subdivide the I.2 bioactive fraction and yielded six subfractions I.2.1-I.2.6. 
Additional testing showed that only subfraction I.2.2 exhibited the anti proliferative, anti-
inflammatory activity observed with the fraction I.2. This subfraction also maintained its 
bioactivity after it was purified using Solid Phase Extraction.  
Finally, UV, IR, NMR and MS enabled the identification of the bioactive compound Sal A.  
In conclusion, three research papers on C. ainetensis water extracts and three on Sal A anti-
inflammatory and anti-tumor activities have been so far published by Ibsar while a fourth 
one is in progress (Al-Saghir et al., 2009; Barbour et al., 2004; El-Najjar et al., 2007; Ghantous 
et al., 2007; Saliba et al., 2009; Talhouk et al., 2008). Prior to our work, there was only one 
published article on Sal A’s biological activity since its isolation (Vajs et al., 1999). Therefore, 
Ibsar has had a major contribution in identifying Sal A’s biological activity and determining 
its mechanisms of action. 
5. Salograviolide A: Overview of biological activities 
To date, C. ainetensis water extract was shown to have antifungal, antibacterial, anti-viral, 
anticancer and anti-inflammatory activities. Sal A on the other hand, was only shown to 
have antifungal, anticancer and anti-inflammatory properties. The group of Vajs et al. 
discovered in 1999 the antifungal activity of Sal A while Ibsar faculty revealed the two 
others. It is unfortunate that no study has so far assessed whether Sal A is responsible for 
the antimicrobial and antiviral potentials exhibited by C. ainetensis water extract.  
Following its isolation from C. nicolai, Sal A was tested against seven fungal species: 
Aspergillus niger, A. ochraceus, Penicillium ochrochloron, Cladosporium cladosporoides, Fusarium 
tricinctum, Phomopsis helianthi and Trichoderma viride (Vajs et al., 1999). Each strain was 
inoculated in the center of a plate with or without Sal A addition to the nutritional agar 
media. After incubation at 20°C for three weeks, the percentage of fungi inhibition was 
determined by comparing the diameter of each fungal strain colony inoculated in the 
presence of Sal A to that of the control inoculated without Sal A. The results showed that Sal 
A inhibited all the fungi strains except Trichoderma viride. Subsequently the use of different 
concentrations of Sal A enabled the determination of the Minimum Inhibitory Concentration 
(MICs) to inhibit the mycelial growth of the respective fungal species. 
To test for the inflammation potential of C. ainetensis water extract, the pro-inflammatory 
cytokine interleukin-6 (IL-6) was chemically induced in mammary epithelial cells (CID-9 
and Scp2) by treatment with endotoxin (ET)). The ability of the extract to reverse or prevent 
IL-6 production was then assessed and the results demonstrated that C. ainetensis water 
extract inhibited IL-6 in a dose-dependent manner (Talhouk et al., 2008). It was also shown 
that the extract reversed chemically induced paw edema signs in ET-pretreated Sprague-
Dawley rats as well as thermal hyperalgesia in rats subjected to the hot plate test. Sal A was 
isolated from the water extracts and shown to be responsible for its observed bioactivity. In 
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(a) Centaurea ainetensis and its taxonomy 
 
 
(b) The bioguided fractionation procedure 
Fig. 3. Illustration of the indigenous Lebanese plant Centaurea ainetensis and the bioguided 
fractionation procedure that enabled the isolation of Salograviolide A. The plant picture is 
courtesy of Mr. Khaled Sleem. 
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parallel, the anti-inflammatory property of Sal A was demonstrated in a murine intestinal 
epithelial cell model (Mode K cells) treated with IL-1 and in vivo in a rat model of colonic 
inflammation induced by rectal injection of iodoacetoamide (Al-Saghir et al., 2009). The 
results showed that, similarly to C. ainetensis water extract, Sal A significantly reduced 
inflammatory cytokines and acted as a preventive agent to reduce inflammation. 
C. ainetensis water extract and Sal A were also tested against different types of cancers (El-
Najjar et al., 2007; Ghantous et al., 2007). In vitro, they were both non cytotoxic to normal 
primary murine keratinocytes while they preferentially inhibited neoplastic benign tumors 
and squamous cell carcinoma growth in a dose-dependent manner. The selective 
antiproliferative effects were confirmed in leukemic cells at the metastatically invasive 
stages as well as in human colon carcinomas. Sal A was also tested in combination with 
another sesquiterpene lactone, the Iso-seco-tanapartholide (TNP) extracted from Achillea 
damascene, against human colon cancer cell lines (Gali-Muhtasib, unpublished findings). The 
study demonstrated a synergistic apoptotic effect of both sesquiterpene lactones that failed 
to induce apoptosis when tested alone at the same low concentrations. Finally in vivo, the 
intraperitoneal water extract injection in Balb/c mice before chemically inducing colon 
cancer reduced drastically the mean size of aberrant crypt foci which is indicative of the 
extract’s cancer preventive activity. 
6. Salograviolide A and inflammation: Mechanisms and targets 
 Natural products derivatives have contributed over the last 25 years to approximately one 
fourth of the anti-inflammatory drugs used in the clinic (Newman & Cragg, 2007). In 2008, 
18 additional natural product derived drugs were being tested at different clinical stages 
(Harvey, 2008). Terpenoids including sesquiterpene lactones have also reached clinical trials 
as potential anti-inflammatory agents. For instance, andrographolide; a labdane diterpenoid 
derived from the plant Andrographis paniculata of the Acanthacaea family, reached phase II 
clinical trials for rheumatoid arthritis. The sesquiterpene lactone parthenolide that made it 
to phase I cancer clinical trials, has also reached phase II and III clinical trials for the 
treatment of allergic contact dermatitis (refer to http://www.clinicaltrials.gov/).  
Drugs with anti-inflammatory activities have common targets and modes of action that lead 
to the downregulation of the signs of inflammation as well as the chemical mediators 
controlling the mechanisms of inflammation. Elements of the complement system, 
angiogenic factors, prostaglandins, cytokines such as interleukins and matrix 
metalloproteinases (MMPs) are some of the most common inflammatory mediators.  
Prostaglandins play a role in the modulation of blood flow. They are derived from the 
arachidonic acid due to the action of two prostaglandins H synthases isoforms known as the 
cyclooxygenases 1 and 2 (COX-1 and COX-2). COX-1 is constitutively expressed in different 
tissues while COX-2 is induced by inflammatory stimuli and is therefore thought to be the 
only isoform involved in propagating the inflammatory response (Larsen & Henson, 1983).  
IL-6 secreted by the macrophages releases proteinases and elastases which bind to IL-6 
receptor and generate signals implicated in humoral inflammation (Heinrich et al., 2003). IL-
1, on the other hand, induces the mobilization of the arachidonic acid and its metabolism 
into prostaglandins thus contributing to cellular inflammation. It was also shown that IL-1 
induces the synthesis of COX-2 through the activation of the nuclear factor Kappa B (NF-κB) 
transcription factor (Larsen & Henson, 1983). NF-κB is a key modulator of inflammation and 
is implicated in inflammation-induced tumor formation as well (Karin & Greten, 2005). It is 
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known to promote the expression of target genes of the inflammation response such as 
interleukins, COX-2, and inducible nitric-oxide synthase (iNOS) (Mazor et al., 2000).  
Finally, components of the MMP family have been reported to act in wound healing and 
embryogenesis (Mainardi et al., 1991). Gelatinase A or MMP-2 (72 KDa) and gelatinase B or 
MMP-9 (92 KDa) have been identified as pro-inflammatory agents. They enable the 
digestion of components of the basement membrane; a function that is referred to as 
gelatinolysis (Birkedal-Hansen et al., 1993).  
Sal A and C. ainetensis water extract were shown to modulate some of these major players of 
the inflammatory response. They both inhibit IL-6 expression (Talhouk et al., 2008) and IL-1-
induced COX-2 expression by interfering with their synthesis (Al-Saghir et al., 2009). Only 
the effect of the water extract on the expression levels of the gelatinases A and B was 
assessed. The results indicate that the water extract decreased the expression of both 
proteins with preferential inhibition of gelatinase B 9 h post treatment with endotoxin 
(Talhouk et al., 2008). Similarly, only the effect of Sal A on the NF-κB signaling was 
investigated. NF-κB is composed of the two subunits p50 and p65 and is only active after 
translocation of the subunits into the nucleus and their dimerization. In normal conditions, 
NF-κB is inactive due to its retention in the cytoplasm by the inhibitor of NF-κB (IκB). Pro-
inflammatory stimuli such as IL-1 cause the phosphorylation of the IκB by the inhibitor of 
NFκB- ǃ (IKK). The phosphorylation in return leads to IκB degradation enabling thus the 
translocation to the cytoplasm and the dimerization of the NF-κB subunits, their binding to 
target DNA sequences, initiation of transcription and activation of the NF-κB transduction 
pathway (Baeuerele & Baltimore, 1996). 
It was demonstrated that Sal A inhibits the NF-κB activation by two mechanisms. The first 
involved the stabilization of IκB, since combination treatment of Sal A with IL-1 decreased 
the degradation of IκB observed in response to treatment with IL-1 alone. The second 
involved inhibiting NF-κB translocation and binding to DNA, since the incubation of cells 
with Sal A after IL-1 addition (hence after IκB degradation) still caused a reduction in the 
activity of NF-κB (Fig. 4) (Al-Saghir et al., 2009).  
7. Salograviolide A and cancer: Mechanisms and targets  
 The mechanism behind the anticancer activity of sesquiterpene lactones has been 
extensively investigated. For example, parthenolide was shown to induce cell cycle arrest, 
promote cell differentiation and trigger apoptosis (Pajak et al., 2008). The molecular basis for 
parthenolide activity in cancer cells include among others, inhibiting NF-κB and stimulating 
apoptosis by accumulation of reactive oxygen species (ROS) as well as by regulating the 
levels of anti-apoptotic and pro-apoptotic proteins (Pajak et al., 2008). Interestingly, 
parthenolide showed a synergistic effect when used in combination with paclitaxel and 
increased apoptosis in breast cancer cells (Patel et al., 2000). 
As mentioned earlier, C. ainetensis crude extract and Sal A were tested against skin, colon 
and blood cancer cell lines and showed selective antineoplastic effects with no cytotoxicity 
to normal cells. At the cellular level, C. ainetensis crude extract induced G0/G1 cell cycle 
arrest in neoplastic epidermal cells while Sal A increased the population in Pre-G1. In 
accordance with this finding, the levels of cyclin D1 whose activity is required for the G1/S 
transition were reduced (Li et al., 2011). On the other hand, the levels of the tumor 
suppressors p16 and p21 which are associated with greater susceptibility to chemotherapy 
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and with calcium induced differentiation in keratinocytes, respectively were increased 
(Hochhauser, 1997; Di Cunto et al., 1998, as cited in Ghantous et al., 2007). Moreover, p21 
proteins were differentially regulated: they were upregulated in the presence of the crude 
extract which was consistent with the observed G0/G1 cell cycle arrest, whereas their 
upregulation in the presence of Sal A was found to be transient. This transient upregulation 
of p21 has been reported as critical for its role in differentiation (Di Cunto et al., 1998).  
 
 
 
Fig. 4. Anti-inflammatory cascade triggered by Sal A. Details of the mechanism are 
explained in section 6 above. 
In addition to cell cycle modulation, characteristic signs of apoptosis such as the partial and 
complete condensation of the chromatin were noted in the presence of Sal A. Furthermore, 
the ratio of the pro-apoptotic protein Bax to the anti-apoptotic protein Bcl-2 was found to be 
elevated. Bax and Bcl-2 have counteracting roles regarding the mitochondrial membrane 
permeabilization and thus the high ratio of Bax to Bcl-2 reflects the permeabilization of the 
mitochondrial membrane to release factors such as cytochrome c and the apoptosis inducing 
factor that will induce cell death. In conjunction, a considerable amount of ROS accumulated 
in the cells in the presence of Sal A. In fact, the accumulation of ROS was even shown to 
precede the growth inhibition and indicated an oxidant role of Sal A in these cells. Finally, 
the crude extract and Sal A had a contradictory regulatory effect on NF-κB. The crude plant 
extract decreased in a dose-dependent manner the binding of NF-κB to the DNA without 
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affecting the expression level of IκB, whereas Sal A increased it.  It is worth noting that in 
cancer, the role of NF-κB activation or inhibition is in itself conflicting. NF-κB can be best 
described as a double edged sword for its activation can promote tumorigenesis (by 
inducing inflammatory mediators) or promote differentiation and thus inhibit 
tumorigenesis (Seitz et al., 1998, as cited in Ghantous et al., 2007). 
In addition, the crude extract was assessed in human colon cancers and showed both an 
increase in p21 protein level of expression and in the ratio of Bax to Bcl-2 proteins. In colon 
cancer, cyclin B1 levels were decreased by the extract, while they were found to be 
unaffected by neither Sal A nor the extract in skin cancer. Cyclin B1 decrease is important 
for the exit from mitosis and for the cytokinesis (Takizawa & Morgan, 2000, as cited in El-
Najjar et al., 2007). Another protein which was differentially modulated in skin vs colon 
cancer is p53. In colon cancer, the crude extract increased the expression levels of the p53 
protein, while the levels were unaffected in skin cancer.  
In leukemic cells, similarly to what was shown with the other two types of cancers, the 
extract induced pre-G1 cell cycle arrest, increased the levels of p53 and p21 as well as the 
ratio of Bax to Bcl-2, and decreased cyclin D1 levels. In addition, the secretion of the vascular 
endothelial growth factor (VEGF) was significantly decreased by Sal A and the crude 
extract, adding VEGF to the list of targets of Sal A (El-Sabban, unpublished findings). 
Finally, Sal A was tested in combination with TNP against human colon cancer cell lines 
(Gali-Muhtasib, unpublished findings). At low concentrations, Sal A and TNP induced 
G2/M cell cycle arrest when tested separately. At the same low concentrations, the 
combination of Sal A and TNP synergistically inhibited tumor growth and triggered 
apoptosis. ROS, which increased by a factor of 25 upon combination treatment, were found 
to be responsible for the synergistic-induced cell death. The pretreatment of the colorectal 
cancer cells with the antioxidant N-acetyl-L-cysteine (NAC), which diminishes the 
intracellular ROS, reversed the synergistic anti-proliferative effect and protected the cells 
from apoptosis and therefore confirmed the implication of ROS in the induction of 
apoptosis. Moreover, p38 kinase, the extracellular signal regulated kinase (ERK) and the c-
Jun N-terminal kinase (JNK) of the mitogen-activated protein kinases (MAPK) pathway 
were found to be phosphorylated and thus induced after the combination treatment. 
Literature strongly advocates for the MAPK pathway implication in ROS induced cell death 
(Zhang et al., 2003). Using specific inhibitors of both ERK (usually involved in mitogenic 
signals and cellular proliferation), and of p38 (associated with stress along with JNK and 
commonly known as the stress activated protein kinases (Lewis et al., 1998)) abolished the 
apoptotic synergistic effect of the combination treatment and emphasized the pathway’s 
association to cell death. Further studies with Sal A and TNP suggested a cross-talk between 
ROS, JNK and Bcl-2 family in the induction of apoptosis. ROS accumulation was found to 
induce Bax relocalization to the mitochondrial membrane on the one hand and to decrease 
the ani-apoptotic Bcl-2 expression levels on the other (Gali-Muhtasib, unpublished findings). 
Bcl-2 decrease was also associated with a maximal JNK activation which suggested that JNK 
might play a role in further inactivation of Bcl-2. In accordance with our findings several 
studies have reported the involvement of JNK but not ERK nor p38 in the phosphorylation 
and inactivation of Bcl-2 (Srivasta et al., 1999). 
Taken together these results indicate a promising chemotherapeutic effect for using Sal A 
alone or in combination against various cancer types.  
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Fig. 5. Anticancer cascade triggered by the combination of Sal A and TNP in colon cancer 
cells. The combination caused increase in ROS and activation of MAPK molecules, ERK, 
JNK and p38 leading to apoptosis. It is still unclear whether apoptosis is associated with the 
modulation of p21, p53, and cyclin B1 proteins or the release of cytochrome c from 
mitochondria. 
8. Conclusion and future direction 
 Cancer progression is characterized by seven hallmarks: sustaining proliferative signaling, 
insensitivity to growth suppressors, evading apoptosis, acquisition of replicative 
immortality, induction of angiogenesis, activation of invasion and metastasis and finally 
chronic inflammation (Colotta F. Et al., 2009).   
In a nutshell, the evidence that has been collected so far by multiple investigators suggests 
that Sal A is a promising compound for cancer drug discovery for it acts at least on three 
cancer hallmarks: it upregulates tumor suppressors, triggers apoptosis and downregulates 
the mediators of inflammation. Its selectivity toward tumor cells and ability to target 
multiple pathways involved in inflammation and cancer imply that this compound is 
unlikely to have a single target that is responsible for its biological activities. Although a 
large body of information supports the role of Sal A against cancer and inflammation, there 
are yet no studies assessing its toxicology profiles or its absorption, distribution and 
metabolism in animals and humans. Such studies are warranted to better determine its 
potential for future applications in the clinical setting whether alone or in combination with 
standard clinical drugs. 
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